Updated Mar 23, 2026 by PCF Group
PCF Group S.A. approved a capital increase on 10 February 2023 through the issuance of new Series E ordinary bearer shares.
The capital injection is strategically intended to increase PCF Group’s equity stake in its Katowice-based subsidiary, Incuvo S.A.
Existing shareholders have been denied pre-emptive rights to purchase the newly issued Series E shares.
The board is pursuing the formal dematerialisation of the new shares and their subsequent listing on the Warsaw Stock Exchange.
The issuance requires a statutory amendment to the company’s articles to formally incorporate the new Series E share class.
This corporate action follows the company's previously disclosed intent to strengthen its financial position and investment in Incuvo S.A. as outlined in report No. 2/2023.
PCF Group S.A. approved a capital increase on 10 February 2023 through the issuance of new Series E ordinary bearer shares.
The capital injection is strategically intended to increase PCF Group’s equity stake in its Katowice-based subsidiary, Incuvo S.A.
Existing shareholders have been denied pre-emptive rights to purchase the newly issued Series E shares.
The board is pursuing the formal dematerialisation of the new shares and their subsequent listing on the Warsaw Stock Exchange.
The issuance requires a statutory amendment to the company’s articles to formally incorporate the new Series E share class.
This corporate action follows the company's previously disclosed intent to strengthen its financial position and investment in Incuvo S.A. as outlined in report No. 2/2023.